Foresight Diagnostics and the University of Washington School of Medicine and Fred Hutch Cancer Center have announced the ...

In this video, Arvind Dasari, MD, MS, discussed data from multiple ASCO Gastrointestinal Cancers Symposium presentations highlighting the use of ctDNA as a minimal residual disease in colorectal ...

Patients who received cilta-cel had improvements in progression-free survival and overall survival if they had sustained a minimal residual disease-negative complete response or better for at least 1 ...

Foresight Diagnostics Inc., a Boulder-based cancer diagnostics company that specialized in the development of ultra-sensitive minimal residual disease, or MRD, detection, recently expanded its ...

Discover how ctDNA revolutionizes multiple myeloma monitoring, tracking disease progression, and improving personalized ...

The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have ...

The investigational immunotherapy bexmarilimab has been granted orphan drug designation from the FDA for patients with ...

Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cance ...

BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced today the publication of a peer-reviewed study in Nature ...